Pacira Pharmaceuticals Inc (PCRX.OQ)
PCRX.OQ on NASDAQ Stock Exchange Global Select Market
34.13USD
10:56am EDT
34.13USD
10:56am EDT
Price Change (% chg)
$0.20 (+0.59%)
$0.20 (+0.59%)
Prev Close
$33.93
$33.93
Open
$34.36
$34.36
Day's High
$34.43
$34.43
Day's Low
$33.90
$33.90
Volume
23,104
23,104
Avg. Vol
115,354
115,354
52-wk High
$35.86
$35.86
52-wk Low
$14.46
$14.46
About
Pacira Pharmaceuticals, Inc. is a United States-based pharmaceutical company. The Company develops non-opioid products for postsurgical pain control. Its products include EXPAREL (bupivacaine liposome injectable suspension) is a liposome injection of bupivacaine, an amide-type local anesthetic; DepoCyt(e) (cytarabine liposome... (more)
Overall
| Beta: | -- |
| Market Cap (Mil.): | $1,121.29 |
| Shares Outstanding (Mil.): | 33.05 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| PCRX.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 37.93 | 37.76 |
| EPS (TTM): | -1.95 | -- | -- |
| ROI: | -51.03 | 19.48 | 18.76 |
| ROE: | -118.06 | 20.17 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| DURECT Corporation (DRRX.OQ) | $1.26 | 0.00 |
| Hospira, Inc. (HSP.N) | $41.86 | +1.16 |
| Kimberly Clark Corp (KMB.N) | $98.80 | 0.00 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Wright Reports
|
$460.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: New Constructs, LLC
|
$25.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

